Ultra-Rapid Cardiotoxicity of the Hepatitis C Virus Protease Inhibitor BILN 2061 in the Urokinase-Type Plasminogen Activator Mouse

This publication has 34 references indexed in Scilit:

• Global epidemiology of hepatitis C virus infection
  The Lancet Infectious Diseases, 2005
• Antiviral efficacy of NS3‐serine protease inhibitor BILN‐2061 in patients with chronic genotype 2 and 3 hepatitis C†‡
  Hepatology, 2005
• Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients
  Gastroenterology, 2004
• Diagnosis, management, and treatment of hepatitis C†
  Hepatology, 2004
• An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
  Nature, 2003
• Hepatitis C Virus Infection
  New England Journal of Medicine, 2001
• Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection
  Hepatology, 1998
• Hepatic Failure and Lactic Acidosis Due to Fialuridine (FIAU), an Investigational Nucleoside Analogue for Chronic Hepatitis B
  New England Journal of Medicine, 1995
• Replacement of Diseased Mouse Liver by Hepatic Cell Transplantation
  Science, 1994
• Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene
  Cell, 1991